Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial

NCT06042569 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

174

Enrollment

OTHER

Sponsor class

Conditions

Anatomic Stage I Breast Cancer AJCC v8
Anatomic Stage II Breast Cancer AJCC v8
Anatomic Stage III Breast Cancer AJCC v8
HER2-Negative Breast Carcinoma

Interventions

DRUG: Cyclophosphamide
DRUG: Docetaxel
OTHER: Medical Chart Review
OTHER: Questionnaire Administration

Sponsor

City of Hope Medical Center

Collaborators

[object Object]
[object Object]